References
- Haines JD, Inglese M, Casaccia P. Axonal damage in multiple sclerosis. Mt Sinai J Med. 2011 Mar-Apr;78(2):231–43. doi: https://doi.org/10.1002/msj.20246
- National Clinical Guideline C. National Institute for Health and Care Excellence: Clinical Guidelines. Multiple Sclerosis: Management of Multiple Sclerosis in Primary and Secondary Care. London: National Institute for Health and Care Excellence (UK) Copyright (c) National Clinical Guideline Centre, 2014.; 2014.
- Bando Y. Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis. Neural Regen Res. 2015 Oct;10(10):1584–5. doi: https://doi.org/10.4103/1673-5374.165287
- Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol. 2009 Jun;9(6):440–7. doi: https://doi.org/10.1038/nri2548
- Poorolajal J, Mazdeh M, Saatchi M, Talebi Ghane E, Biderafsh A, Lotfi B, et al. Multiple sclerosis associated risk factors: a case-control study. Iran J Public Health. 2015;44(11):1498–505.
- VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 Aug;58(8):1095–109. doi: https://doi.org/10.1038/sj.ejcn.1601952
- Inaloo S, Haghbin S. Multiple sclerosis in children. Iran J Child Neurol. 2013 Spring;7(2):1–10.
- Ghasemi N. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 2017;19(1):1–10.
- O’Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci. 2012;13(9):11718–52. doi: https://doi.org/10.3390/ijms130911718
- Duhen R, Glatigny S, Arbelaez CA, Blair TC, Oukka M, Bettelli E. Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet. J Immunol. 2013;190(9):4478–82. doi: https://doi.org/10.4049/jimmunol.1203172
- Lee PW, Severin ME, Lovett-Racke AE. TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis. Eur J Immunol. 2017;47(3):446–53. doi: https://doi.org/10.1002/eji.201646716
- Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164(4):1079–106. doi: https://doi.org/10.1111/j.1476-5381.2011.01302.x
- Cockburn N, Pateman K, Taing MW, Pradhan A, Ford PJ. Managing the oral side-effects of medications used to treat multiple sclerosis. Aust Dent J. 2017 Sep;62(3):331–6. doi: https://doi.org/10.1111/adj.12510
- Yadav V, Shinto L, Bourdette D. Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol. 2010 May;6(3):381–95. doi: https://doi.org/10.1586/eci.10.12
- Kordali S, Kotan R, Mavi A, Cakir A, Ala A, Yildirim A. Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils. J Agric Food Chem. 2005;53(24):9452–8. doi: https://doi.org/10.1021/jf0516538
- Behbahani BA, Shahidi F, Yazdi FT, Mortazavi SA, Mohebbi M. Antioxidant activity and antimicrobial effect of tarragon (Artemisia dracunculus) extract and chemical composition of its essential oil. J Food Meas Charact. 2017;11(2):847–63. doi: https://doi.org/10.1007/s11694-016-9456-3
- Reza S M, Hamideh M, Zahra S. The nociceptive and anti-inflammatory effects of Artemisia dracunculus L. aqueous extract on fructose fed male rats. Evidence-Based Complementary Altern Med. 2015;5(1):35–40.
- Pelisch N, Dan T, Ichimura A, Sekiguchi H, Vaughan DE, De Strihou CVY, et al. Plasminogen activator inhibitor-1 antagonist TM5484 attenuates demyelination and axonal degeneration in a mice model of multiple sclerosis. PloS one. 2015;10(4):e0124510. doi: https://doi.org/10.1371/journal.pone.0124510
- Kruisbeek AM. Isolation of mouse mononuclear cells. Curr Protoc Immunol. 2000;39(1):3.1–3.1.5. doi: https://doi.org/10.1002/0471142735.im0301s39
- Khosravi AR, Shokri H, Eshghi S. In vitro lymphoproliferative response and cytokine production in mice with experimental disseminated candidiasis. Iran J Basic Med Sci. 2017;20(2):193–8.
- Jimenez-Valera M, Moreno E, Amat MA, Ruiz-Bravo A. Modification of mitogen-driven lymphoproliferation by ceftriaxone in normal and immunocompromised mice. Int J Antimicrob Agents. 2003;22(6):607–12. doi: https://doi.org/10.1016/j.ijantimicag.2003.04.001
- Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P. Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Investig. 2011;40(6):627–39. doi: https://doi.org/10.3109/08820139.2011.573041
- Haghmorad D, Mahmoudi MB, Mahmoudi M, Rab SZT, Rastin M, Shegarfi H, et al. Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Med J. 2014;29(3):185–9. doi: https://doi.org/10.5001/omj.2014.46
- Tian K-w, Zhang Y-y, Jiang H, Han S. Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE. Sci Rep. 2018;8(1):1–17.
- Kim BS, Jin Y-H, Meng L, Hou W, Kang HS, Park HS, et al. IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease. J Neuroinflammation. 2012;9(1):217.
- Rodgers JM, Miller SD. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J Biol Med. 2012;9(1):217–60.
- Huang W-J, Chen W-W, Zhang X. Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med. 2017;13(6):3163–6. doi: https://doi.org/10.3892/etm.2017.4410
- Yang C, Lai W, Zhou J, Zheng X, Cai Y, Yang W, et al. Betaine ameliorates experimental autoimmune encephalomyelitis by inhibiting dendritic cell–derived IL-6 production and Th17 differentiation. 2018;200(4):1316–24.
- Shen R, Deng W, Li C, Zeng G. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2015;24(2):224–31. doi: https://doi.org/10.1016/j.intimp.2014.12.015
- Zheng Q, Yang T, Fang L, Liu L, Liu H, Zhao H, et al. Effects of Bu Shen Yi Sui Capsule on Th17/treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis. BMC Complement Altern Med. 2015;15:1–14. doi:10.1186/s12906-015-0572-0.
- Haghmorad D, Salehipour Z, Nosratabadi R, Rastin M, Kokhaei P, Mahmoudi MB, et al. Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice. J Immunotoxicol. 2016;13(6):885–96. doi: https://doi.org/10.1080/1547691X.2016.1223768
- Mohammed Ibrahem N. Extraction and characterization of Iraqi artemisia dracunculus dried aerial parts extract though HPLC and GC-MS analysis with evaluation of its antitumor activity against 7, 12-dimethylbenze (a) anthracene induced skin cancer in mice. Int J Pharm Pharm Sci. 2017;9(5):34–42. doi: https://doi.org/10.22159/ijpps.2017v9i5.16875
- Abtahi Froushani SM, Zarei L. Esmaeili Gouvarchin Ghaleh H, Mansori Motlagh B. Estragole and methyl-eugenol-free extract of Artemisia dracunculus possesses immunomodulatory effects. Avicenna J Phytomed. 2016;6(5):526–34.
- Aggarwal S, Shailendra G, Ribnicky DM, Burk D, Karki N, Qingxia Wang MS. An extract of Artemisia dracunculus L. stimulates insulin secretion from β cells, activates AMPK and suppresses inflammation. J Ethnopharmacol. 2015;170:98–105. doi: https://doi.org/10.1016/j.jep.2015.05.003
- Bandli J K, Heidari R. The evaluation of antioxidant Activities and phenolic compounds in leaves and inflorescence of Artemisia dracunculus L. by HPLC. J Med Plants. 2014;3(51):41–50.